Evidence map›Paper›PMID 25527659›Full record

ArticleThe Journal of nutrition2015

In HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency.

Anna Bogusiewicz, Gunnar Boysen, Donald M Mock

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Biotin: From Nutrition to Therapeutics.The Journal of nutrition · 2017
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Anna BogusiewiczDepartment of Biochemistry and Molecular Biology and bogusiewiczanna@uams.edu mockdonaldm@uams.edu.
Gunnar BoysenFay W Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR.
Donald M MockDepartment of Biochemistry and Molecular Biology and bogusiewiczanna@uams.edu mockdonaldm@uams.edu.
Arturo Michelena University · VEUniversity of Arkansas for Medical Sciences · US

Funding

Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Aspects of Biotin NutritionR37DK036823 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI MOCK, DONALD M · 2002 to 2011
$3.5M
NCATS NIH HHS UL1 TR000039NIDDK NIH HHS DK79890-01S1NIDDK NIH HHS R01 DK79890NIDDK NIH HHS R37 DK 36823NIDDK NIH HHS R37 DK36823-26S1
6 · The paper itself

Abstract

backgroundA large number of birth defects are related to nutrient deficiencies; concern that biotin deficiency is teratogenic in humans is reasonable. Surprisingly, studies indicate that increased urinary 3-hydroxyisovalerylcarnitine (3HIAc), a previously validated marker of biotin deficiency, is not a valid biomarker in pregnancy.

objectiveIn this study we hypothesized that coexisting carnitine deficiency can prevent the increase in 3HIAc due to biotin deficiency.

methodsWe used a 2-factor nutrient depletion design to induce isolated and combined biotin and carnitine deficiency in HepG2 cells and then repleted cells with carnitine. To elucidate the metabolic pathogenesis, we quantitated intracellular and extracellular free carnitine, acylcarnitines, and acylcarnitine ratios using liquid chromatography-tandem mass spectrometry.

resultsRelative to biotin-sufficient, carnitine-sufficient cells, intracellular acetylcarnitine increased by 90%, propionylcarnitine more than doubled, and 3HIAc increased by >10-fold in biotin-deficient, carnitine-sufficient (BDCS) cells, consistent with a defensive mechanism in which biotin-deficient cells transesterify the acyl-coenzyme A (acyl-CoA) substrates of the biotin-dependent carboxylases to the related acylcarnitines. Likewise, in BDCS cells, the ratio of acetylcarnitine to malonylcarnitine and the ratio of propionylcarnitine to methylmalonylcarnitine both more than tripled, and the ratio of 3HIAc to 3-methylglutarylcarnitine (MGc) increased by >10-fold. In biotin-deficient, carnitine-deficient (BDCD) cells, the 3 substrate-derived acylcarnitines changed little, but the substrate:product ratios were masked to a lesser extent. Moreover, carnitine repletion unmasked biotin deficiency in BDCD cells as shown by increases in acetylcarnitine, propionylcarnitine, and 3HIAc (each increased by >50-fold). Likewise, ratios of acetylcarnitine:malonylcarnitine, propionylcarnitine:methylmalonylcarnitine, and 3HIAc:MGc all increased by >8-fold.

conclusionsOur findings provide strong evidence that coexisting carnitine deficiency masks some indicators of biotin deficiency and support the potential importance of the ratios of acylcarnitines arising from the acyl-CoA substrates and products for biotin-dependent carboxylases in detecting the biotin deficiency that is masked by coexisting carnitine deficiency.

Indexed as

Acyl Coenzyme ABiomarkersBiotinCarnitineChromatography, LiquidCulture MediaFalse Negative ReactionsFemaleHep G2 CellsHumansPregnancyTandem Mass Spectrometry3-hydroxyisovalerylcarnitineacylcarnitineAcyl Coenzyme ABiomarkersBiotinCarnitineCulture Mediapropionylcarnitinebiomarkersbiotincarnitineintermediary metabolismmass spectrometry

Identifiers

PMID25527659
PMCPMC4264022
OpenAlexW2101537332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.